Results 261 to 270 of about 6,667,826 (304)
Some of the next articles are maybe not open access.
Minimal residual disease in melanoma
Seminars in Surgical Oncology, 2001AbstractA number of specific genes encoding for melanosomal proteins are selectively expressed in melanocytes and melanomas. For detection of circulating melanoma cells, the expression of the tyrosinase gene is most widely used. Several cohorts of melanoma patients from single institutions have been analyzed by various research groups for the presence ...
N, Max, U, Keilholz
openaire +2 more sources
2012
Disease relapse remains a major problem in a significant proportion of patients treated for cancer. Molecular monitoring of minimal residual disease (MRD), usually using a real-time quantitative PCR-based approach, is an important tool for risk stratification and prognostication and can be used as a guide for optimizing clinical management in these ...
Wesley O. Greaves, Rajyalakshmi Luthra
+5 more sources
Disease relapse remains a major problem in a significant proportion of patients treated for cancer. Molecular monitoring of minimal residual disease (MRD), usually using a real-time quantitative PCR-based approach, is an important tool for risk stratification and prognostication and can be used as a guide for optimizing clinical management in these ...
Wesley O. Greaves, Rajyalakshmi Luthra
+5 more sources
Detection of Minimal Residual Disease
1995The ability to detect neoplastic infiltration is important not only for the accurate staging of disease at diagnosis but also to monitor the response to therapy. Although adult patients with advanced malignancies often achieve clinical complete remission, the majority of these patients ultimately relapse.
J, Gribben, L, Nadler
openaire +2 more sources
Markers of Minimal Residual Disease
1982Current methods employing tumour markers to detect small amounts of residual disease are reviewed with respect to human germ cell, colorectal and breast neoplasms. It is concluded that the assay of tumour markers in body fluids has only limited clinical value. Alternative approaches, such as are afforded by radioimmunodetection and immunocytochemistry,
openaire +2 more sources
Kinetics of Minimal Residual Disease
1979The development of a rational approach to adjuvant chemotherapy of cancer depends upon at least four factors: 1. Recognition that micrometastases are frequently disseminated and established prior to the time of surgery for a primary cancer; 2.
openaire +2 more sources
Residual disease after mastectomy
The Lancet Oncology, 2020Nigel J, Bundred +3 more
openaire +4 more sources
2009
During the past 30 years, survival rates after allogeneic stem cell transplantation (SCT) have been improved substantially. These improvements have mostly been due to better graft matching using genomic HLA typing, GVHD prophylaxis, infection management, and supportive care [1-3]. The incidence of leukemia relapse and death rates after relapse, however,
openaire +1 more source
During the past 30 years, survival rates after allogeneic stem cell transplantation (SCT) have been improved substantially. These improvements have mostly been due to better graft matching using genomic HLA typing, GVHD prophylaxis, infection management, and supportive care [1-3]. The incidence of leukemia relapse and death rates after relapse, however,
openaire +1 more source